Healthy Extracts (HYEX) Cash from Financing Activities (2015 - 2025)
Healthy Extracts (HYEX) reported Cash from Financing Activities of -$486274.0 for Q4 2025, down 1506.99% on a YoY basis from $34561.4 in Q4 2024, and down 280.89% quarter-over-quarter from $268829.0 in Q3 2025.
Healthy Extracts (HYEX) Cash from Financing Activities (2015 - 2025) Analysis & Trends
Healthy Extracts has reported Cash from Financing Activities for 11 years, with the latest figure at -$486274.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Financing Activities fell 1506.99% year-over-year to -$486274.0; the trailing twelve-month figure through Dec 2025 stood at -$186906.0 (up 1.31% YoY), and the FY2025 full-year result was -$186906.0, up 1.31% from the prior year.
- Cash from Financing Activities for Q4 2025 stood at -$486274.0, down from $268829.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $846880.0 in Q1 2021, with the low at -$486274.0 in Q4 2025.
- Historically, Cash from Financing Activities has averaged $69648.0 across 5 years, with a median of $35458.5 in 2023.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities jumped 3755.28% — and 2025, when it plunged 1506.99%.
- Healthy Extracts' Cash from Financing Activities stood at $77199.0 in 2021, then soared by 79.7% to $138730.0 in 2022, then tumbled by 159.52% to -$82574.0 in 2023, then soared by 63.35% to -$30260.0 in 2024, then sank by 1506.99% to -$486274.0 in 2025.
- The last three Cash from Financing Activities figures came in at -$486274.0 (Q4 2025), $268829.0 (Q3 2025), and $83782.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -840.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1.48 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -86.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -65.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.47 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -77.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -11.62 Mn |
| 10 | Healthy Extracts | - | - | 957,429.00 | -486,274.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -486,274.00 |
| Dec 31, 2025 | -486,274.00 |
| Sep 30, 2025 | 268,829.00 |
| Sep 30, 2025 | 268,829.00 |
| Jun 30, 2025 | 83,782.00 |
| Jun 30, 2025 | 83,782.00 |
| Mar 31, 2025 | -53,243.00 |
| Mar 31, 2025 | -53,243.00 |
| Dec 31, 2024 | -30,260.00 |
| Dec 31, 2024 | -30,260.00 |
| Sep 30, 2024 | -100,109.00 |
| Sep 30, 2024 | -100,109.00 |
| Jun 30, 2024 | -108,166.00 |
| Jun 30, 2024 | -108,166.00 |
| Mar 31, 2024 | 49,146.00 |
| Mar 31, 2024 | 49,146.00 |
| Dec 31, 2023 | -82,574.00 |
| Dec 31, 2023 | -82,574.00 |
| Sep 30, 2023 | 21,771.00 |
| Sep 30, 2023 | 21,771.00 |